These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 36197074)

  • 21. Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics.
    Meo SA; Meo AS; Al-Jassir FF; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8012-8018. PubMed ID: 34982465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transmission networks of SARS-CoV-2 in Coastal Kenya during the first two waves: A retrospective genomic study.
    Agoti CN; Ochola-Oyier LI; Dellicour S; Mohammed KS; Lambisia AW; de Laurent ZR; Morobe JM; Mburu MW; Omuoyo DO; Ongera EM; Ndwiga L; Maitha E; Kitole B; Suleiman T; Mwakinangu M; Nyambu JK; Otieno J; Salim B; Musyoki J; Murunga N; Otieno E; Kiiru JN; Kasera K; Amoth P; Mwangangi M; Aman R; Kinyanjui S; Warimwe G; Phan M; Agweyu A; Cotten M; Barasa E; Tsofa B; Nokes DJ; Bejon P; Githinji G
    Elife; 2022 Jun; 11():. PubMed ID: 35699426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level.
    Akerman A; Milogiannakis V; Jean T; Esneau C; Silva MR; Ison T; Fichter C; Lopez JA; Chandra D; Naing Z; Caguicla J; Li D; Walker G; Amatayakul-Chantler S; Roth N; Manni S; Hauser T; Barnes T; Condylios A; Yeang M; Wong M; Foster CSP; Sato K; Lee S; Song Y; Mao L; Sigmund A; Phu A; Vande More AM; Hunt S; Douglas M; Caterson I; Britton W; Sandgren K; Bull R; Lloyd A; Triccas J; Tangye S; Bartlett NW; Darley D; Matthews G; Stark DJ; Petoumenos K; Rawlinson WD; Murrell B; Brilot F; Cunningham AL; Kelleher AD; Aggarwal A; Turville SG
    EBioMedicine; 2023 Apr; 90():104545. PubMed ID: 37002990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Event rates and incidence of post-COVID-19 condition in hospitalised SARS-CoV-2 positive children and young people and controls across different pandemic waves: exposure-stratified prospective cohort study in Moscow (StopCOVID).
    Pazukhina E; Rumyantsev M; Baimukhambetova D; Bondarenko E; Markina N; El-Taravi Y; Petrova P; Ezhova A; Andreeva M; Iakovleva E; Bobkova P; Pikuza M; Trefilova A; Abdeeva E; Galiautdinova A; Filippova Y; Bairashevskaia A; Zolotarev A; Bulanov N; DunnGalvin A; Chernyavskaya A; Kondrikova E; Kolotilina A; Gadetskaya S; Ivanova YV; Turina I; Eremeeva A; Fedorova LA; Comberiati P; Peroni DG; Nekliudov N; Genuneit J; Reyes LF; Brackel CLH; Mazankova L; Miroshina A; Samitova E; Borzakova S; Carson G; Sigfrid L; Scott JT; McFarland S; Greenhawt M; Buonsenso D; Semple MG; Warner JO; Olliaro P; Osmanov IM; Korsunskiy AA; Munblit D;
    BMC Med; 2024 Feb; 22(1):48. PubMed ID: 38302974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of SARS-Cov-2 omicron variant with the previously identified SARS-Cov-2 variants in Egypt, 2020-2022: insight into SARS-Cov-2 genome evolution and its impact on epidemiology, clinical picture, disease severity, and mortality.
    Kandeel A; Moatasim Y; Fahim M; Bahaaeldin H; El-Shesheny R; Roshdy WH; Kamel MN; Shawky S; Gomaa M; Naguib A; Guindy NE; Deghedy O; Kamel R; Khalifa M; Galal R; Hassany M; Mahmoud G; Kandeil A; Afifi S; Mohsen A; Fattah MA; Kayali G; Ali MA; Abdelghaffar K
    BMC Infect Dis; 2023 Aug; 23(1):542. PubMed ID: 37596534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.
    Nyberg T; Ferguson NM; Nash SG; Webster HH; Flaxman S; Andrews N; Hinsley W; Bernal JL; Kall M; Bhatt S; Blomquist P; Zaidi A; Volz E; Aziz NA; Harman K; Funk S; Abbott S; ; Hope R; Charlett A; Chand M; Ghani AC; Seaman SR; Dabrera G; De Angelis D; Presanis AM; Thelwall S
    Lancet; 2022 Apr; 399(10332):1303-1312. PubMed ID: 35305296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of maternal and neonatal outcomes of COVID-19 before and after SARS-CoV-2 omicron emergence in maternity facilities in Malawi (MATSurvey): data from a national maternal surveillance platform.
    Mndala L; Monk EJM; Phiri D; Riches J; Makuluni R; Gadama L; Kachale F; Bilesi R; Mbewe M; Likaka A; Chapuma C; Kumwenda M; Maseko B; Ndamala C; Kuyere A; Munthali L; Henrion MYR; Masesa C; Lissauer D
    Lancet Glob Health; 2022 Nov; 10(11):e1623-e1631. PubMed ID: 36155136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of medically assisted reproduction with offspring cord blood DNA methylation across cohorts.
    Caramaschi D; Jungius J; Page CM; Novakovic B; Saffery R; Halliday J; Lewis S; Magnus MC; London SJ; Håberg SE; Relton CL; Lawlor DA; Elliott HR
    Hum Reprod; 2021 Jul; 36(8):2403-2413. PubMed ID: 34136910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baseline Sequencing Surveillance of Public Clinical Testing, Hospitals, and Community Wastewater Reveals Rapid Emergence of SARS-CoV-2 Omicron Variant of Concern in Arizona, USA.
    Smith MF; Holland SC; Lee MB; Hu JC; Pham NC; Sullins RA; Holland LA; Mu T; Thomas AW; Fitch R; Driver EM; Halden RU; Villegas-Gold M; Sanders S; Krauss JL; Nordstrom L; Mulrow M; White M; Murugan V; Lim ES
    mBio; 2023 Feb; 14(1):e0310122. PubMed ID: 36622143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern.
    Aggarwal A; Akerman A; Milogiannakis V; Silva MR; Walker G; Stella AO; Kindinger A; Angelovich T; Waring E; Amatayakul-Chantler S; Roth N; Manni S; Hauser T; Barnes T; Condylios A; Yeang M; Wong M; Jean T; Foster CSP; Christ D; Hoppe AC; Munier ML; Darley D; Churchill M; Stark DJ; Matthews G; Rawlinson WD; Kelleher AD; Turville SG
    EBioMedicine; 2022 Oct; 84():104270. PubMed ID: 36130476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study.
    Pinato DJ; Aguilar-Company J; Ferrante D; Hanbury G; Bower M; Salazar R; Mirallas O; Sureda A; Plaja A; Cucurull M; Mesia R; Townsend S; Jackson A; Dalla Pria A; Newsom-Davis T; Handford J; Sita-Lumsden A; Apthorp E; Vincenzi B; Bertuzzi A; Brunet J; Lambertini M; Maluquer C; Pedrazzoli P; Biello F; Sinclair A; Bawany S; Khalique S; Rossi S; Rogers L; Murphy C; Belessiotis K; Carmona-García MC; Sharkey R; García-Illescas D; Rizzo G; Perachino M; Saoudi-Gonzalez N; Doonga K; Fox L; Roldán E; Gaidano G; Ruiz-Camps I; Bruna R; Patriarca A; Martinez-Vila C; Cantini L; Zambelli A; Giusti R; Mazzoni F; Caliman E; Santoro A; Grosso F; Parisi A; Queirolo P; Aujayeb A; Rimassa L; Prat A; Tucci M; Libertini M; Grisanti S; Mukherjee U; Diamantis N; Fusco V; Generali D; Provenzano S; Gennari A; Tabernero J; Cortellini A;
    Lancet Oncol; 2022 Jul; 23(7):865-875. PubMed ID: 35660139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Omicron new variant BA.2.86 (Pirola): Epidemiological, biological, and clinical characteristics - a global data-based analysis.
    Meo SA; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9470-9476. PubMed ID: 37843359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiphospholipid antibodies and neurological manifestations in acute COVID-19: A single-centre cross-sectional study.
    Benjamin LA; Paterson RW; Moll R; Pericleous C; Brown R; Mehta PR; Athauda D; Ziff OJ; Heaney J; Checkley AM; Houlihan CF; Chou M; Heslegrave AJ; Chandratheva A; Michael BD; Blennow K; Vivekanandam V; Foulkes A; Mummery CJ; Lunn MP; Keddie S; Spyer MJ; Mckinnon T; Hart M; Carletti F; Jäger HR; Manji H; Zandi MS; Werring DJ; Nastouli E; Simister R; Solomon T; Zetterberg H; Schott JM; Cohen H; Efthymiou M;
    EClinicalMedicine; 2021 Sep; 39():101070. PubMed ID: 34401683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study.
    Graham MS; Sudre CH; May A; Antonelli M; Murray B; Varsavsky T; Kläser K; Canas LS; Molteni E; Modat M; Drew DA; Nguyen LH; Polidori L; Selvachandran S; Hu C; Capdevila J; ; Hammers A; Chan AT; Wolf J; Spector TD; Steves CJ; Ourselin S
    Lancet Public Health; 2021 May; 6(5):e335-e345. PubMed ID: 33857453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study.
    Frampton D; Rampling T; Cross A; Bailey H; Heaney J; Byott M; Scott R; Sconza R; Price J; Margaritis M; Bergstrom M; Spyer MJ; Miralhes PB; Grant P; Kirk S; Valerio C; Mangera Z; Prabhahar T; Moreno-Cuesta J; Arulkumaran N; Singer M; Shin GY; Sanchez E; Paraskevopoulou SM; Pillay D; McKendry RA; Mirfenderesky M; Houlihan CF; Nastouli E
    Lancet Infect Dis; 2021 Sep; 21(9):1246-1256. PubMed ID: 33857406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-vaccination infection rates and modification of COVID-19 symptoms in vaccinated UK school-aged children and adolescents: A prospective longitudinal cohort study.
    Molteni E; Canas LS; Kläser K; Deng J; Bhopal SS; Hughes RC; Chen L; Murray B; Kerfoot E; Antonelli M; Sudre CH; Pujol JC; Polidori L; May A; Hammers PA; Wolf J; Spector PTD; Steves CJ; Ourselin PS; Absoud M; Modat M; Duncan PEL
    Lancet Reg Health Eur; 2022 Aug; 19():100429. PubMed ID: 35821715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changing composition of SARS-CoV-2 lineages and rise of Delta variant in England.
    Mishra S; Mindermann S; Sharma M; Whittaker C; Mellan TA; Wilton T; Klapsa D; Mate R; Fritzsche M; Zambon M; Ahuja J; Howes A; Miscouridou X; Nason GP; Ratmann O; Semenova E; Leech G; Sandkühler JF; Rogers-Smith C; Vollmer M; Unwin HJT; Gal Y; Chand M; Gandy A; Martin J; Volz E; Ferguson NM; Bhatt S; Brauner JM; Flaxman S;
    EClinicalMedicine; 2021 Sep; 39():101064. PubMed ID: 34401689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis.
    COVID-19 Forecasting Team
    Lancet; 2023 Mar; 401(10379):833-842. PubMed ID: 36930674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Viral kinetics of SARS-CoV-2 following onset of COVID-19 in symptomatic patients infected with the ancestral strain and omicron BA.2 in Hong Kong: a retrospective observational study.
    Lin Y; Wu P; Tsang TK; Wong JY; Lau EHY; Yang B; Leung GM; Cowling BJ
    Lancet Microbe; 2023 Sep; 4(9):e722-e731. PubMed ID: 37659420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ten months of temporal variation in the clinical journey of hospitalised patients with COVID-19: An observational cohort.
    ; Hall MD; Baruch J; Carson G; Citarella BW; Dagens A; Dankwa EA; Donnelly CA; Dunning J; Escher M; Kartsonaki C; Merson L; Pritchard M; Wei J; Horby PW; Rojek A; Olliaro PL
    Elife; 2021 Nov; 10():. PubMed ID: 34812731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.